http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. A commonly used class of biologic response modifying drugs can cause acute liver injury with elevated liver enzymes, according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association. Patients with inflammatory diseases such as Chron's disease or ulcerative colitis often are prescribed tumor necrosis factor-alpha (TNF-α) antagonists, which modify the body's response to infection. Patients with inflammatory arthropathies and selected dermatological diseases are also candidates to receive such compounds. http://medicalxpress.com/news/2013-04-frequently-biologic-agents-acute-liver.html Diseases, Conditions, Syndromes Mon, 29 Apr 2013 18:52:34 EST news286480349 The cost of one year's treatment of rheumatoid arthritis with new generation drugs is more than the per capita gross domestic product of 26 European countries, reveals research published online in the Annals of the Rheumatic Diseases. http://medicalxpress.com/news/2013-03-wide-disparities-access-latest-rheumatoid.html Arthritis & Rheumatism Wed, 06 Mar 2013 18:30:01 EST news281808813 (HealthDay)—Doctors who treat patients with psoriasis show wide variation in their beliefs about the safety and effectiveness of psoriasis treatments, according to a study published in the February issue of the Journal of the American Academy of Dermatology. http://medicalxpress.com/news/2013-02-doctors-perceptions-psoriasis-therapies-vary.html Diseases, Conditions, Syndromes Thu, 07 Feb 2013 13:20:01 EST news279464855 Three separate studies presented today at the American College of Gastroenterology's (ACG) 77th Annual Scientific meeting in Las Vegas help to advance understanding of the differences between African American and Caucasian patients with Inflammatory Bowel Disease (IBD) and provide clinicians with new insight on how racial disparities involving disease characteristics, infliximab use, and fistulizing Crohn's disease may impact their patients—and their decisions on how best to manage the disease. http://medicalxpress.com/news/2012-10-explore-racial-disparities-ibd-symptoms.html Diseases, Conditions, Syndromes Mon, 22 Oct 2012 09:19:30 EST news270116340 Researchers at Emory University have found that a medication that inhibits inflammation may offer new hope for people with difficult-to-treat depression. The study was published Sept. 3 in the online version of Archives of General Psychiatry. http://medicalxpress.com/news/2012-09-inflammation-depression.html Psychology & Psychiatry Mon, 03 Sep 2012 16:00:06 EST news265888737 New research confirms no significant difference in the rates of death among patients with rheumatoid arthritis (RA) who were exposed to one of several TNF inhibitors used to treat RA, adalimumab (Humira), etanercept (Enbrel), and infliximab (Remicade). This population-based study of RA patients in Sweden—the first to compare mortality rates among patients treated with individual TNF inhibitors—is now available in Arthritis & Rheumatism, a journal published by Wiley on behalf of the American College of Rheumatology (ACR). http://medicalxpress.com/news/2012-08-difference-death-patients-exposed-common.html Arthritis & Rheumatism Wed, 08 Aug 2012 00:00:01 EST news263569158 (HealthDay) -- All patients with psoriasis should be screened for hepatitis B surface antigen and hepatitis B core antibody prior to the initiation of tumor necrosis factor-alpha inhibitor therapy, according to research published online June 25 in the Journal of the American Academy of Dermatology. http://medicalxpress.com/news/2012-07-hep-screening-urged-tnf-alpha-inhibitor.html Diseases, Conditions, Syndromes Sun, 01 Jul 2012 13:51:13 EST news260369467 Patients with inflammatory rheumatic diseases (IRD) treated with anti-tumour necrosis factor medications (anti-TNFs) have a 75% greater risk of developing herpes zoster, or shingles, than patients treated with traditional disease modifying anti-rheumatic drugs (DMARDs), according to a meta-analysis presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism. http://medicalxpress.com/news/2012-06-treatment-anti-tnfs-shingles-percent.html Arthritis & Rheumatism Thu, 07 Jun 2012 07:39:52 EST news258273584 Biological agents used to treat rheumatoid arthritis seem to be associated with an increased risk of skin cancer, indicates a systematic review of published research in the Annals of the Rheumatic Diseases. http://medicalxpress.com/news/2011-09-biological-agents-rheumatoid-arthritis-skin.html Cancer Thu, 08 Sep 2011 05:17:02 EST news234677807